| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.009 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |